{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T14:24:20Z","timestamp":1777040660768,"version":"3.51.4"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T00:00:00Z","timestamp":1741651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>This cross-sectional study investigated mental health conditions, physical functioning, and health-related quality of life (HRQOL) in adults with short-statured skeletal dysplasia conditions across three centres; in New York, Newcastle-upon-Tyne and Norway.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Questionnaires were sent to patients registered at the centres or distributed to adults attending clinics. The questionnaires included demographics, medical history, depression (PHQ-8), anxiety (GAD-7), pain catastrophizing, activities of daily living (HAQ), and HRQOL (SF 36\/RAND-36 and PROMIS-29).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Of the 142 participants, 62 (44%) had achondroplasia (n\u2009=\u200959) or hypochondroplasia (n\u2009=\u20093), and 80 (56%) had other skeletal dysplasia conditions (OSD), the largest groups being multiple epiphyseal dysplasia (n\u2009=\u200914), diastrophic dysplasia (n\u2009=\u20099), spondyloepiphyseal dysplasia congenita (n\u2009=\u20099) and pseudoachondroplasia (n\u2009=\u20098). Mean age was 41 (range 18\u201380) years. A prior psychiatric diagnosis was reported by 36%. Clinically significant symptoms of depression (PHQ-8 score\u2009\u2265\u200910) and anxiety (GAD-7 score\u2009\u2265\u200910) were reported by 23% and 13%. Almost all (99%) reported pain, while 9% had clinically significant levels of pain catastrophizing. For daily activities, the most affected domains were activities, reach and walking. The prevalence of current depression and anxiety symptoms was considerably higher in the study population than in the general US population. Participants with OSD reported more psychiatric diagnoses, depression and anxiety symptoms, more pain and challenges in performing daily activities, and lower HRQOL compared to participants with achondroplasia\/hypochondroplasia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Adults with skeletal dysplasia appear to have an increased risk for mental health issues and reduced physical functioning, which may impact HRQOL. These findings underscore the importance of including a formal assessment of mental health, pain and daily activities as part of regular medical follow-up across the lifespan in these patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13023-025-03610-w","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T09:55:21Z","timestamp":1741686921000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mental health conditions, physical functioning, and health-related quality of life in adults with a skeletal dysplasia: a cross-sectional multinational study"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2069-0638","authenticated-orcid":false,"given":"Elisabeth","family":"Fagereng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Su","family":"Htwe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chloe","family":"Derocher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Bertoli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Carter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Mette","family":"Bredahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taran","family":"Blakstvedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micheal","family":"Wright","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathleen","family":"Raggio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2804-5783","authenticated-orcid":false,"given":"Svein","family":"Fredwall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,11]]},"reference":[{"issue":"5","key":"3610_CR1","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1002\/ajmg.a.63132","volume":"191","author":"S Unger","year":"2023","unstructured":"Unger S, Ferreira CR, Mortier GR, Ali H, Bertola DR, Calder A, et al. Nosology of genetic skeletal disorders: 2023 revision. Am J Med Genet A. 2023;191(5):1164\u2013209.","journal-title":"Am J Med Genet A"},{"key":"3610_CR2","unstructured":"Organization WH. Congenital disorders World Health Organization: World Health Organization (WHO); [Available from: https:\/\/www.who.int\/health-topics\/congenital-anomalies#tab=tab_1."},{"issue":"6","key":"3610_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1097\/GIM.0b013e3181daae9b","volume":"12","author":"D Krakow","year":"2010","unstructured":"Krakow D, Rimoin DL. The skeletal dysplasias. Genet Med. 2010;12(6):327\u201341.","journal-title":"Genet Med"},{"issue":"1","key":"3610_CR4","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1186\/s13023-020-01397-6","volume":"15","author":"SO Fredwall","year":"2020","unstructured":"Fredwall SO, Steen U, de Vries O, Rustad CF, Eggesb\u00f8 HB, Weedon-Fekj\u00e6r H, et al. High prevalence of symptomatic spinal stenosis in Norwegian adults with achondroplasia: a population-based study. Orphanet J Rare Dis. 2020;15(1):123.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3610_CR5","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/cge.12045","volume":"84","author":"Y Alade","year":"2013","unstructured":"Alade Y, Tunkel D, Schulze K, McGready J, Jallo G, Ain M, et al. Cross-sectional assessment of pain and physical function in skeletal dysplasia patients. Clin Genet. 2013;84(3):237\u201343.","journal-title":"Clin Genet"},{"issue":"6","key":"3610_CR6","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s11136-019-02102-2","volume":"28","author":"SE Jennings","year":"2019","unstructured":"Jennings SE, Ditro CP, Bober MB, Mackenzie WG, Rogers KJ, Conway L, et al. Prevalence of mental health conditions and pain in adults with skeletal dysplasia. Qual Life Res. 2019;28(6):1457\u201364.","journal-title":"Qual Life Res"},{"issue":"5","key":"3610_CR7","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s11136-016-1455-7","volume":"26","author":"N Dhiman","year":"2017","unstructured":"Dhiman N, Albaghdadi A, Zogg CK, Sharma M, Hoover-Fong JE, Ain MC, et al. Factors associated with health-related quality of life (HRQOL) in adults with short stature skeletal dysplasias. Qual Life Res. 2017;26(5):1337\u201348.","journal-title":"Qual Life Res"},{"issue":"1","key":"3610_CR8","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1080\/15017410902909118","volume":"12","author":"T Shakespeare","year":"2010","unstructured":"Shakespeare T, Thompson S, Wright M. No laughing matter: medical and social experiences of restricted growth. Scand J Disabil Res. 2010;12(1):19\u201331.","journal-title":"Scand J Disabil Res"},{"issue":"1\u20133","key":"3610_CR9","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.jad.2008.06.026","volume":"114","author":"K Kroenke","year":"2009","unstructured":"Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord. 2009;114(1\u20133):163\u201373.","journal-title":"J Affect Disord"},{"issue":"9","key":"3610_CR10","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606\u201313.","journal-title":"J Gen Intern Med"},{"issue":"541","key":"3610_CR11","first-page":"650","volume":"57","author":"S Gilbody","year":"2007","unstructured":"Gilbody S, Richards D, Barkham M. Diagnosing depression in primary care using self-completed instruments: UK validation of PHQ-9 and CORE-OM. Br J Gen Pract. 2007;57(541):650\u20132.","journal-title":"Br J Gen Pract"},{"issue":"1","key":"3610_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12888-020-03013-0","volume":"21","author":"L Wisting","year":"2021","unstructured":"Wisting L, Johnson SU, Bulik CM, Andreassen OA, Ro O, Bang L. Psychometric properties of the Norwegian version of the Patient Health Questionnaire-9 (PHQ-9) in a large female sample of adults with and without eating disorders. BMC Psychiatry. 2021;21(1):6.","journal-title":"BMC Psychiatry"},{"issue":"10","key":"3610_CR13","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JB, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166(10):1092\u20137.","journal-title":"Arch Intern Med"},{"issue":"3","key":"3610_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1097\/MLR.0b013e318160d093","volume":"46","author":"B Lowe","year":"2008","unstructured":"Lowe B, Decker O, Muller S, Brahler E, Schellberg D, Herzog W, et al. Validation and standardization of the Generalized Anxiety Disorder Screener (GAD-7) in the general population. Med Care. 2008;46(3):266\u201374.","journal-title":"Med Care"},{"key":"3610_CR15","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.3389\/fpsyg.2019.01713","volume":"10","author":"SU Johnson","year":"2019","unstructured":"Johnson SU, Ulvenes PG, Oktedalen T, Hoffart A. Psychometric properties of the general anxiety disorder 7-item (GAD-7) scale in a heterogeneous psychiatric sample. Front Psychol. 2019;10:1713.","journal-title":"Front Psychol"},{"issue":"9","key":"3610_CR16","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.jpain.2017.05.003","volume":"18","author":"BD Darnall","year":"2017","unstructured":"Darnall BD, Sturgeon JA, Cook KF, Taub CJ, Roy A, Burns JW, et al. Development and validation of a daily pain catastrophizing scale. J Pain. 2017;18(9):1139\u201349.","journal-title":"J Pain"},{"key":"3610_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1471-2474-13-111","volume":"13","author":"L Fernandes","year":"2012","unstructured":"Fernandes L, Storheim K, Lochting I, Grotle M. Cross-cultural adaptation and validation of the Norwegian pain catastrophizing scale in patients with low back pain. BMC Musculoskelet Disord. 2012;13:111.","journal-title":"BMC Musculoskelet Disord"},{"key":"3610_CR18","unstructured":"Sullivan MJ. The pain catastrophizing scale: user manual. Montreal: McGill University. 2009;1:36."},{"issue":"1","key":"3610_CR19","first-page":"167","volume":"30","author":"B Bruce","year":"2003","unstructured":"Bruce B, Fries JF. The Stanford Health Assessment Questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol. 2003;30(1):167\u201378.","journal-title":"J Rheumatol"},{"issue":"S11","key":"3610_CR20","doi-asserted-by":"publisher","first-page":"S297","DOI":"10.1002\/acr.20638","volume":"63","author":"DK White","year":"2011","unstructured":"White DK, Wilson JC, Keysor JJ. Measures of adult general functional status. Arthritis Care Res. 2011;63(S11):S297-307.","journal-title":"Arthritis Care Res"},{"issue":"4","key":"3610_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.3109\/03009748809098795","volume":"17","author":"C Ekdahl","year":"1988","unstructured":"Ekdahl C, Eberhardt K, Andersson SI, Svensson B. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol. 1988;17(4):263\u201371.","journal-title":"Scand J Rheumatol"},{"issue":"5","key":"3610_CR22","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/07853890109002089","volume":"33","author":"RD Hays","year":"2001","unstructured":"Hays RD, Morales LS. The RAND-36 measure of health-related quality of life. Ann Med. 2001;33(5):350\u20137.","journal-title":"Ann Med"},{"issue":"1","key":"3610_CR23","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1177\/1534734618762226","volume":"17","author":"J Ahn","year":"2018","unstructured":"Ahn J, Del Core MA, Wukich DK, Liu GT, Lalli T, VanPelt MD, et al. Scoring mental health quality of life with the SF-36 in patients with and without diabetes foot complications. Int J Low Extrem Wounds. 2018;17(1):30\u20135.","journal-title":"Int J Low Extrem Wounds"},{"key":"3610_CR24","doi-asserted-by":"crossref","unstructured":"Farivar SS, Cunningham WE, Hays RD. Correlated physical and mental health summary scores for the SF-36 and SF-12 Health Survey, V.I. Health Qual Life Outcomes. 2007;5:54.","DOI":"10.1186\/1477-7525-5-54"},{"issue":"1","key":"3610_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1136\/jech.53.1.46","volume":"53","author":"C Jenkinson","year":"1999","unstructured":"Jenkinson C, Stewart-Brown S, Petersen S, Paice C. Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health. 1999;53(1):46\u201350.","journal-title":"J Epidemiol Community Health"},{"issue":"1","key":"3610_CR26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1186\/s12955-017-0625-9","volume":"15","author":"AM Garratt","year":"2017","unstructured":"Garratt AM, Stavem K. Measurement properties and normative data for the Norwegian SF-36: results from a general population survey. Health Qual Life Outcomes. 2017;15(1):51.","journal-title":"Health Qual Life Outcomes"},{"issue":"5","key":"3610_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.jval.2019.02.004","volume":"22","author":"D Cella","year":"2019","unstructured":"Cella D, Choi SW, Condon DM, Schalet B, Hays RD, Rothrock NE, et al. PROMIS(\u00ae) adult health profiles: efficient short-form measures of seven health domains. Value Health. 2019;22(5):537\u201344.","journal-title":"Value Health"},{"issue":"1","key":"3610_CR28","first-page":"79","volume":"31","author":"T Pan","year":"2022","unstructured":"Pan T, Mulhern B, Viney R, Norman R, Tran-Duy A, Hanmer J, et al. Evidence on the relationship between PROMIS-29 and EQ-5D: a literature review. Qual Life Res Int J Qual Life Asp Treat Care Rehabil. 2022;31(1):79\u201389.","journal-title":"Qual Life Res Int J Qual Life Asp Treat Care Rehabil"},{"issue":"7","key":"3610_CR29","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1007\/s11136-018-1842-3","volume":"27","author":"RD Hays","year":"2018","unstructured":"Hays RD, Spritzer KL, Schalet BD, Cella D. PROMIS\u00ae-29 v2. 0 profile physical and mental health summary scores. Qual Life Res. 2018;27(7):1885\u201391.","journal-title":"Qual Life Res"},{"issue":"4","key":"3610_CR30","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s11136-018-1785-8","volume":"27","author":"F Fischer","year":"2018","unstructured":"Fischer F, Gibbons C, Coste J, Valderas JM, Rose M, Lepl\u00e8ge A. Measurement invariance and general population reference values of the PROMIS Profile 29 in the UK, France, and Germany. Qual Life Res. 2018;27(4):999\u20131014.","journal-title":"Qual Life Res"},{"issue":"1","key":"3610_CR31","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s41687-021-00357-3","volume":"5","author":"AM Garratt","year":"2021","unstructured":"Garratt AM, Coste J, Rouquette A, Valderas JM. The Norwegian PROMIS-29: psychometric validation in the general population for Norway. J Patient Rep Outcomes. 2021;5(1):86.","journal-title":"J Patient Rep Outcomes"},{"key":"3610_CR32","first-page":"1","volume":"379","author":"MA Villarroel","year":"2020","unstructured":"Villarroel MA, Terlizzi EP. Symptoms of depression among adults: United States, 2019. NCHS Data Brief. 2020;379:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"3610_CR33","first-page":"1","volume":"378","author":"EP Terlizzi","year":"2020","unstructured":"Terlizzi EP, Villarroel MA. Symptoms of generalized anxiety disorder among adults: United States, 2019. NCHS Data Brief. 2020;378:1\u20138.","journal-title":"NCHS Data Brief"},{"key":"3610_CR34","unstructured":"Ware J, Snoww K, Ma K, Bg G. SF36 health survey: manual and interpretation guide. Lincoln, RI: Quality Metric, Inc, 1993. 1993;30"},{"issue":"4","key":"3610_CR35","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/ajmg.a.20127","volume":"120a","author":"SE Gollust","year":"2003","unstructured":"Gollust SE, Thompson RE, Gooding HC, Biesecker BB. Living with achondroplasia in an average-sized world: an assessment of quality of life. Am J Med Genet A. 2003;120a(4):447\u201358.","journal-title":"Am J Med Genet A"},{"issue":"4","key":"3610_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1891","volume":"10","author":"R Shediac","year":"2022","unstructured":"Shediac R, Moshkovich O, Gerould H, Ballinger R, Williams A, Bellenger MA, et al. Experiences of children and adolescents living with achondroplasia and their caregivers. Mol Genet Genom Med. 2022;10(4): e1891.","journal-title":"Mol Genet Genom Med"},{"issue":"17","key":"3610_CR37","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.3109\/09638288.2013.853842","volume":"36","author":"AK Schanke","year":"2014","unstructured":"Schanke AK, Thorsen K. A life-course perspective on stigma-handling: resilience in persons of restricted growth narrated in life histories. Disabil Rehabil. 2014;36(17):1464\u201373.","journal-title":"Disabil Rehabil"},{"key":"3610_CR38","unstructured":"Holt N, Bremner A, Sutherland E, Vliek M, Passer M, Smith R. Psychology: the science of mind and behaviour, 4e: McGraw Hill; 2019."},{"issue":"4","key":"3610_CR39","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3109\/09540261.2014.928270","volume":"26","author":"J Allen","year":"2014","unstructured":"Allen J, Balfour R, Bell R, Marmot M. Social determinants of mental health. Int Rev Psychiatry. 2014;26(4):392\u2013407.","journal-title":"Int Rev Psychiatry"},{"issue":"2","key":"3610_CR40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1093\/aje\/kwf182","volume":"157","author":"V Lorant","year":"2003","unstructured":"Lorant V, Deli\u00e8ge D, Eaton W, Robert A, Philippot P, Ansseau M. Socioeconomic inequalities in depression: a meta-analysis. Am J Epidemiol. 2003;157(2):98\u2013112.","journal-title":"Am J Epidemiol"},{"issue":"8","key":"3610_CR41","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1038\/s41436-021-01165-2","volume":"23","author":"JE Hoover-Fong","year":"2021","unstructured":"Hoover-Fong JE, Alade AY, Hashmi SS, Hecht JT, Legare JM, Little ME, et al. Achondroplasia Natural History Study (CLARITY): a multicenter retrospective cohort study of achondroplasia in the United States. Genet Med. 2021;23(8):1498\u2013505.","journal-title":"Genet Med"},{"issue":"1","key":"3610_CR42","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13023-023-02652-2","volume":"18","author":"M Maghnie","year":"2023","unstructured":"Maghnie M, Semler O, Guillen-Navarro E, Selicorni A, Heath KE, Haeusler G, et al. Lifetime impact of achondroplasia study in Europe (LIAISE): findings from a multinational observational study. Orphanet J Rare Dis. 2023;18(1):56.","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"3610_CR43","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/art.20048","volume":"50","author":"E Krishnan","year":"2004","unstructured":"Krishnan E, Sokka T, Hakkinen A, Hubert H, Hannonen P. Normative values for the Health Assessment Questionnaire disability index: benchmarking disability in the general population. Arthritis Rheum. 2004;50(3):953\u201360.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"3610_CR44","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/rheumatology\/kei181","volume":"45","author":"T Uhlig","year":"2006","unstructured":"Uhlig T, Haavardsholm EA, Kvien TK. Comparison of the Health Assessment Questionnaire (HAQ) and the modified HAQ (MHAQ) in patients with rheumatoid arthritis. Rheumatology (Oxford). 2006;45(4):454\u20138.","journal-title":"Rheumatology (Oxford)"},{"issue":"36","key":"3610_CR45","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.15585\/mmwr.mm6936a2","volume":"69","author":"RA Cree","year":"2020","unstructured":"Cree RA, Okoro CA, Zack MM, Carbone E. Frequent mental distress among adults, by disability status, disability type, and selected characteristics\u2014United States, 2018. MMWR Morb Mortal Wkly Rep. 2020;69(36):1238\u201343.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"1\u20133","key":"3610_CR46","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.jad.2007.01.015","volume":"103","author":"KM Scott","year":"2007","unstructured":"Scott KM, Bruffaerts R, Tsang A, Ormel J, Alonso J, Angermeyer MC, et al. Depression-anxiety relationships with chronic physical conditions: results from the World Mental Health Surveys. J Affect Disord. 2007;103(1\u20133):113\u201320.","journal-title":"J Affect Disord"},{"issue":"12","key":"3610_CR47","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-033353","volume":"9","author":"N Uhlenbusch","year":"2019","unstructured":"Uhlenbusch N, Lowe B, Depping MK. Perceived burden in dealing with different rare diseases: a qualitative focus group study. BMJ Open. 2019;9(12): e033353.","journal-title":"BMJ Open"},{"key":"3610_CR48","doi-asserted-by":"crossref","unstructured":"Constantinides C, Landis SH, Jarrett J, Quinn J, Ireland PJ. Quality of life, physical functioning, and psychosocial function among patients with achondroplasia: a targeted literature review. Disabil Rehabil. 2021;1\u201313.","DOI":"10.1080\/09638288.2021.1963853"},{"issue":"4","key":"3610_CR49","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1007\/s00520-020-05801-6","volume":"29","author":"TXM Tran","year":"2021","unstructured":"Tran TXM, Park J, Lee J, Jung Y-S, Chang Y, Cho H. Utility of the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure primary health outcomes in cancer patients: a systematic review. Support Care Cancer. 2021;29(4):1723\u201339.","journal-title":"Support Care Cancer"},{"issue":"8","key":"3610_CR50","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1093\/rheumatology\/kex055","volume":"56","author":"L Kwakkenbos","year":"2017","unstructured":"Kwakkenbos L, Thombs BD, Khanna D, Carrier M-E, Baron M, Furst DE, et al. Performance of the patient-reported outcomes measurement information system-29 in scleroderma: a scleroderma patient-centered intervention network cohort study. Rheumatology. 2017;56(8):1302\u201311.","journal-title":"Rheumatology"},{"key":"3610_CR51","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000480","author":"AP Desai","year":"2023","unstructured":"Desai AP, Madathanapalli A, Tang Q, Orman ES, Lammert C, Patidar KR, et al. PROMIS Profile-29 is a valid instrument with distinct advantages over legacy instruments for measuring the quality of life in chronic liver disease. Hepatology. 2023. https:\/\/doi.org\/10.1097\/HEP.0000000000000480.","journal-title":"Hepatology"},{"issue":"8","key":"3610_CR52","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.jval.2014.09.005","volume":"17","author":"BM Craig","year":"2014","unstructured":"Craig BM, Reeve BB, Brown PM, Cella D, Hays RD, Lipscomb J, et al. US valuation of health outcomes measured using the PROMIS-29. Value Health. 2014;17(8):846\u201353.","journal-title":"Value Health"},{"issue":"3","key":"3610_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41574-021-00595-x","volume":"18","author":"R Savarirayan","year":"2022","unstructured":"Savarirayan R, Ireland P, Irving M, Thompson D, Alves I, Baratela WAR, et al. International Consensus Statement on the diagnosis, multidisciplinary management and lifelong care of individuals with achondroplasia. Nat Rev Endocrinol. 2022;18(3):173\u201389.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"3610_CR54","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S2352-4642(23)00265-1","volume":"8","author":"R Savarirayan","year":"2024","unstructured":"Savarirayan R, Wilcox WR, Harmatz P, Phillips J 3rd, Polgreen LE, Tofts L, et al. Vosoritide therapy in children with achondroplasia aged 3\u201359 months: a multinational, randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Child Adolesc Health. 2024;8(1):40\u201350.","journal-title":"Lancet Child Adolesc Health"},{"key":"3610_CR55","doi-asserted-by":"crossref","unstructured":"Dauber A, Phillip M, Ferran JM, Kelepouris N, Nedjatian N, Olsen AH, et al. Clinical predictors of good\/poor response to growth hormone treatment in children with idiopathic short stature. Horm Res Paediatr. 2024;1\u201320.","DOI":"10.1159\/000542579"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03610-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-025-03610-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-025-03610-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,13]],"date-time":"2025-03-13T10:42:25Z","timestamp":1741862545000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-025-03610-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3610"],"URL":"https:\/\/doi.org\/10.1186\/s13023-025-03610-w","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,11]]},"assertion":[{"value":"25 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"In New York, the study was approved by the Hospital for Special Surgery Institutional Review Board. In Newcastle upon Tyne, Research Ethics Committee favourable opinion was received from London\u2014Harrow Research Ethics Committee, UK. In Norway, the study was approved by the Regional Committee for Medical and Health Research Ethics (REK), South-Eastern Norway (approval number 278769). Informed consent was obtained from all individual participants included in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"116"}}